The Itch: Allergies, Asthma, Eczema & Immunology24 Juli 2025

#121 - Avapritinib versus Placebo in Indolent Systemic Mastocytosis - PIONEER Trial

What happens when you target the root cause of indolent systemic mastocytosis?

In this episode of The Itch Review, we unpack key findings from the article “Avapritinib versus Placebo in Indolent Systemic Mastocytosis,” published on May 23, 2023, in NEJM Evidence.

Indolent Systemic Mastocytosis (ISM) is a rare chronic disease with life-altering symptoms. Until recently, treatment options were limited. We break down new data from Part 2 of the PIONEER study, which evaluated Avapritinib, a targeted therapy designed to inhibit the KIT D816V mutation that drives ISM.

Dr. Gupta and Dr. Blaiss explain how Avapritinib works, how the study was designed, and what outcomes were measured, including the Total Symptom Score (TSS). Most importantly, we explore what this treatment could mean for patients with moderate to severe ISM.

INFOGRAPHIC

What we cover in our episode about avapritinib versus placebo:

Understanding ISM: How the KIT D816V mutation causes overproduction and overactivation of mast cells.
Why current treatment falls short: The limitations of best supportive care and why many patients remain symptomatic despite multiple medications.
How Avapritinib works: A tyrosine kinase inhibitor that targets the KIT mutation directly, aiming to reduce mast cell activation at its source.
Inside the PIONEER trial: Study design, eligibility criteria, and how outcomes like Total Symptom Score (TSS) and serum tryptase were measured.
What the data showed: Improvements in symptoms, lab markers, and quality of life and what this could mean for long-term ISM care.

The Itch Review, hosted by Dr. Gupta, Kortney, and Dr. Blaiss, explores allergy and immunology studies, breaking down complex research in conversations accessible to clinicians, patients, and caregivers. Each episode provides key insights from journal articles and includes a one-page infographic in the show notes for easy reference.

Made in partnership with The Allergy & Asthma Network.

Thanks to Blueprint Medicines for sponsoring today’s episode.

This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(175)

#173 - Busting the Biggest Biologics Myths for COPD, Asthma, and Nasal Polyps

Starting a biologic can feel intimidating, especially if you are worried it means being on medication forever, or wondering if it will actually replace your inhaler or your next sinus surgery. After t...

3 Sep 33min

#172 - Why Needing Systemic Steroids for Asthma Is a Warning Sign

Needing oral steroids for your asthma is a signal, not just a setback. It could be a sign that your asthma is not actually under control, even if you feel like you're managing it day to day. Dr. Wes S...

27 Aug 39min

#171 - Rescue Inhaler Changes in the Newest Asthma Guidelines

For decades, the rescue inhaler was simple: feel tight, take a puff, breathe easier. But the newest asthma guidelines have changed what's actually recommended inside that inhaler, shifting away from p...

21 Aug 42min

#170 - When Asthma Peak Week Hits Adults

Most asthma peak week coverage focuses on kids heading back to school. But adults with asthma are just as much at risk, and often don't realize it until they're already in trouble. Kortney and Dr. Pa...

13 Aug 29min

#169 - What a School Nurse Wants Parents to Know About Asthma Peak Week

Every September, doctors see a jump in asthma attacks and ER visits. It's called Asthma Peak Week, and it usually hits the third week of September, right when families are settling into their school r...

6 Aug 41min

#168 - Wildfire Smoke and Your Lungs, What You Need to Know

Wildfire smoke used to feel like someone else's problem. Now it can show up on air quality alerts hundreds of miles from any actual fire, and for anyone with asthma, that hazy sky can mean real troubl...

30 Juli 23min

#167 - How Is Chronic Rhinosinusitis Without Nasal Polyps Diagnosed and Treated?

Chronic rhinosinusitis without nasal polyps (CRSsNP) is the type that makes up most chronic sinusitis cases. It's often mistaken for allergies, a lingering cold, or migraines, which can delay a proper...

24 Juli 28min

#166 - How Pregnancy and Your Baby's Gut Microbiome Play a Role in Food Allergy Prevention

Food allergy prevention is something most families think about once a baby starts eating. But the gut microbiome begins developing before birth, and what happens during pregnancy matters for the devel...

16 Juli 21min